KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Medpace Holdings (MEDP) Invested Capital: 2015-2025

Historic Invested Capital for Medpace Holdings (MEDP) over the last 9 years, with Sep 2025 value amounting to $293.6 million.

  • Medpace Holdings' Invested Capital fell 66.69% to $293.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $293.6 million, marking a year-over-year decrease of 66.69%. This contributed to the annual value of $825.5 million for FY2024, which is 47.70% up from last year.
  • According to the latest figures from Q3 2025, Medpace Holdings' Invested Capital is $293.6 million, which was up 70.37% from $172.4 million recorded in Q2 2025.
  • Medpace Holdings' Invested Capital's 5-year high stood at $952.9 million during Q4 2021, with a 5-year trough of $172.4 million in Q2 2025.
  • In the last 3 years, Medpace Holdings' Invested Capital had a median value of $559.0 million in 2023 and averaged $558.2 million.
  • Per our database at Business Quant, Medpace Holdings' Invested Capital skyrocketed by 87.18% in 2024 and then slumped by 77.43% in 2025.
  • Medpace Holdings' Invested Capital (Quarterly) stood at $952.9 million in 2021, then slumped by 54.21% to $436.4 million in 2022, then climbed by 28.09% to $559.0 million in 2023, then spiked by 47.70% to $825.5 million in 2024, then plummeted by 66.69% to $293.6 million in 2025.
  • Its Invested Capital stands at $293.6 million for Q3 2025, versus $172.4 million for Q2 2025 and $593.6 million for Q1 2025.